Target Analysts Slash Their Forecasts After Q2 Results

Target Corporation (NYSE: TGT) reported better-than-expected second-quarter earnings, but lowered its profit forecast.

Target Corporation (NYSE:TGT) reported better-than-expected second-quarter earnings, but lowered its profit forecast.

Target reported a second-quarter FY23 sales decline of 4.9% year-on-year to $24.77 billion, missing the analyst consensus of $25.18 billion. Adjusted EPS of $1.80 beat the analyst consensus of $1.39.

Target lowered FY23 adjusted EPS guidance from $7.75-$8.75 to $7.00-$8.00 (consensus $7.79) and expects comparable sales in a wide range around mid-single-digit decline for the remainder of the year. It sees third-quarter adjusted EPS of $1.20 – $1.60 against the Street view of $1.84; expects a mid-single-digit decline in comparable sales.

Target shares gained 3% to close at $128.75 on Wednesday and added 0.2% in today’s pre-market trading session.

These analysts made changes to their price targets on Target following earnings announcement.

Goldman Sachs cut the price target on Target from $185 to $168. Goldman Sachs analyst Kate McShane maintained a Buy rating.

B of A Securities slashed the price target on Target from $145 to $135. B of A Securities analyst Robert Ohmes maintained a Neutral rating.

BMO Capital lowered the price target on Target from $140 to $130. BMO Capital analyst Kelly Bania maintained a Market Perform rating.

Check This Out: Walmart, Cisco And 3 Stocks To Watch Heading Into Thursday

Total
0
Shares
Related Posts
Read More

Cannabis Cultivation Solutions Provider Agrify And California’s Nature’s Miracle Sign Definitive Merger Deal

Vertical farming technology and infrastructure provider Nature's Miracle Holding Inc. (NASDAQ: NMHI) and Agrify Corporation (NASDAQ: AGFY) announced on Thursday that both parties have signed a definitive agreement and plan of merger. Under the deal, a new wholly-owned subsidiary of Nature's Miracle will merge with and into Agrify, with Agrify surviving the merger as a wholly-owned subsidiary of Nature's Miracle. The signing of the definitive agreement directly follows the previously announced term sheet for the merger, according to a press release.

AGFY